| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Department of Biology, The Johns Hopkins University, Baltimore, Maryland 21218 [J. D. H., J. K., R. C. C. H.]; Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21205 [T. C. W.]; and Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University, Chicago, Illinois 60626 [W. M. K.]
The transcription inhibitor tetra-O-methyl nordihydroguaiaretic acid (M4N) was found to arrest the proliferation of C3, C33a, CEM-T4, and TC-1 cells in culture at the G2 stage of the cell cycle. Investigation into the mechanism of arrest revealed that M4N reduces mRNA levels and subsequent protein production of the cyclin-dependent kinase CDC2, resulting in the inactivation of the CDC2/cyclin B complex (maturation promoting factor). When injected intratumorally in a C3-cell induced C57bl/6 mouse tumor model system, M4N demonstrated substantial tumoricidal activity that correlated with a reduction in tumor cell CDC2 protein levels. These findings suggest that M4N may be a useful chemotherapeutic agent for the control of unregulated cellular proliferation.
This article has been cited by other articles:
![]() |
H.-C. Yeh, C. M. Puleo, T. C. Lim, Y.-P. Ho, P. E. Giza, R. C. C. Huang, and T.-H. Wang A microfluidic-FCS platform for investigation on the dissociation of Sp1-DNA complex by doxorubicin Nucleic Acids Res., December 4, 2006; 34(21): e144 - e144. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Park, C.-C. Chang, Y.-C. Liang, Y. Chung, R. A. Henry, E. Lin, D. E. Mold, and R. C. C. Huang Systemic Treatment with Tetra-O-Methyl Nordihydroguaiaretic Acid Suppresses the Growth of Human Xenograft Tumors Clin. Cancer Res., June 15, 2005; 11(12): 4601 - 4609. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Chang, J. D. Heller, J. Kuo, and R. C. C. Huang Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression PNAS, September 7, 2004; 101(36): 13239 - 13244. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |